Literature DB >> 6411230

Testing the anterior pituitary: hypoglycaemia produced by continuous intravenous insulin infusion.

G H Newman, I A Macdonald, S P Allison.   

Abstract

The response of growth hormone, cortisol, and catecholamines to hypoglycaemia produced by a continuous intravenous infusion of insulin was investigated in 10 normal subjects and 15 patients with pituitary disease. The insulin infusion rate was started at 2 U/hour for adolescents, 4 U/hour for adults, and 6 U/hour for patients with acromegaly. If required the rate was increased during the test depending on changes in blood glucose, measured by a Reflomat with low reading glucose oxidase strips. Stopping the infusion when the blood glucose concentration had fallen to 2.0 mmol/l (36 mg/100 ml) resulted in a maximum further fall of 0.7 mmol/l (13 mg/100 ml) and a subsequent spontaneous rise in blood glucose concentration. The rise was identical in normal subjects and in patients with hypopituitarism, further evidence that pituitary hormones--in contrast to glucagon and catecholamines--are relatively unimportant in the recovery from hypoglycaemia. The only patient who required intravenous glucose to restore normoglycaemia was a patient with longstanding insulin dependent diabetes. A comparison with the conventional bolus injection test showed that continuous intravenous insulin infusion was more reliable in producing adequate but not excessive hypoglycaemia and the hormone responses were equivalent. The continuous intravenous insulin infusion may offer particular advantages in the investigation of growth hormone deficiency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411230      PMCID: PMC1549004          DOI: 10.1136/bmj.287.6392.571

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.

Authors:  J Gerich; J Davis; M Lorenzi; R Rizza; N Bohannon; J Karam; S Lewis; R Kaplan; T Schultz; P Cryer
Journal:  Am J Physiol       Date:  1979-04

2.  Hypoglycemic threshold for human growth hormone release.

Authors:  S M Glick
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

3.  Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man.

Authors:  J V Santiago; W L Clarke; S D Shah; P E Cryer
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

4.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects.

Authors:  F C Greenwood; J Landon; T C Stamp
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

5.  Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

Authors:  J E Gerich; M Langlois; C Noacco; J H Karam; P H Forsham
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

  5 in total
  1 in total

1.  Telfairia occidentalis stimulates hepatic glycolysis and pyruvate production via insulin-dependent and insulin-independent mechanisms.

Authors:  Toyin Mohammed Salman; Mayowa Adewale Iyanda; Abdul-Musawwir Alli-Oluwafuyi; Sheu Oluwadare Sulaiman; Abdullateef Isiaka Alagbonsi
Journal:  Metabol Open       Date:  2021-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.